CDMO services
Lifecore develops, fills, and packages sterile injectable medicines for other drug companies, including work on formulation, process development, and manufacturing at its Minnesota facility.
Customers and revenue model
Lifecore Biomedical Inc
F:LDE
Lifecore Biomedical Inc
F:LDE
Price:
5.55
EUR
-0.89%
Market Closed
Market Cap:
€184.3m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Lifecore Biomedical Inc
F:LDE
|
US |
|
Coastal Financial Corp (EVERETT)
NASDAQ:CCB
|
US |
|
U
|
United Parks & Resorts Inc
F:W2L
|
US |
|
SSI Liquidating Inc
OTC:SCOO
|
US |
|
V
|
Vale SA
F:CVLB
|
BR |
|
B
|
Boeing Co
BMV:BA
|
US |
|
K
|
Kubota Corp
OTC:KUBTF
|
JP |
|
M
|
Minth Group Ltd
F:M3I
|
TW |
|
Penske Automotive Group Inc
NYSE:PAG
|
US |
|
Var Energi ASA
OTC:VREAF
|
NO |
|
T
|
Target Corp
F:DYH
|
US |
|
U
|
UOB-Kay Hian Holdings Ltd
F:4LJ
|
SG |
|
C
|
Coats Group PLC
F:4TC
|
UK |
|
F
|
Fintec Global Bhd
KLSE:FINTEC
|
MY |
|
North American Construction Group Ltd
TSX:NOA
|
CA |
|
N
|
Nucor Corp
DUS:NUO
|
US |
|
Japan Pulp & Paper Co Ltd
OTC:JPPPF
|
JP |
|
N
|
Nanoco Group PLC
OTC:NNOCF
|
UK |
|
C
|
Coloplast A/S
SWB:CBHD
|
DK |
|
Fresenius Medical Care AG & Co KGaA
NYSE:FMS
|
DE |
|
P
|
Puig Brands SA
MAD:PUIG
|
ES |
|
V
|
Vodacom Group Ltd
JSE:VOD
|
ZA |
|
P
|
Public Storage
LSE:0KS3
|
US |
|
A
|
Alstom SA
XETRA:AOMD
|
FR |
Company Overview
Business Description
- Sector
- Health Care
- Industry
- Life Sciences Tools & Services
- Headquarters
- United States of America US
- Employees
- 400
- IPO date
- Feb 15, 1996
Lifecore Biomedical makes and packages sterile injectable medicines for other drug companies. It also manufactures hyaluronic acid, a key ingredient used in some eye, joint, and surgical products. The company sits in the middle of the pharmaceutical supply chain, helping customers turn drug formulas into finished, sterile products that can be sold to hospitals, clinics, and patients.
Its customers are drug developers and pharmaceutical companies that need outside help with manufacturing, especially for products that must be filled into vials or syringes in a clean, tightly controlled environment. Lifecore earns money by charging for contract manufacturing work, development services, and the sale of its hyaluronic acid-based materials. In other words, it gets paid both for making the product and for helping customers move it through the production process.
What makes the business different is that it combines two roles: a specialty ingredient maker and a sterile fill-finish manufacturer. That gives it technical know-how in both raw materials and finished dosage forms, which is useful for customers that need a partner with strict quality controls and experience handling sensitive injectable products.
Continue LDE Research
Other Lifecore Biomedical Inc listings:
